Cargando…
Rivaroxaban treatment for asymptomatic venous thromboembolism: insights from the J’xactly study
BACKGROUND: An established treatment strategy for asymptomatic pulmonary embolism (PE) or deep vein thrombosis (DVT) remains uncertain in Japan; therefore, in this study, we clarify the characteristics and outcomes of symptomatic compared to asymptomatic patients with PE or DVT. METHODS: This prospe...
Autores principales: | Migita, Shohei, Okumura, Yasuo, Fukuda, Ikuo, Nakamura, Mashio, Yamada, Norikazu, Takayama, Morimasa, Maeda, Hideaki, Yamashita, Takeshi, Ikeda, Takanori, Mo, Makoto, Yamazaki, Tsutomu, Hirayama, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440934/ https://www.ncbi.nlm.nih.gov/pubmed/37599351 http://dx.doi.org/10.1186/s12959-023-00528-w |
Ejemplares similares
-
Rivaroxaban Treatment for Patients With Unprovoked or Provoked Venous Thromboembolism ― Subanalysis of the J’xactly Study ―
por: Hisatake, Shinji, et al.
Publicado: (2022) -
Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism ― Subanalysis of the J’xactly Study ―
por: Nakamura, Mashio, et al.
Publicado: (2023) -
Relationship between baseline D-dimer and prognosis in Japanese patients with venous thromboembolism: Insights from the J’xactly study
por: Migita, Shohei, et al.
Publicado: (2023) -
Prognostication of Patients with Pulmonary Thromboembolism with and without Residual Deep Vein Thrombosis: A Subanalysis of the J’xactly Study
por: Yamada, Norikazu, et al.
Publicado: (2023) -
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism ― Insights From the J’xactly Study ―
por: Yamashita, Takeshi, et al.
Publicado: (2022)